Difficulty: Medium
Average Score: 64%
Practice
A healthy 20-day-old male examination reveals a palpable liver margin below the right costal margin; lab findings: white blood count, 18700/mm3; hemoglobin, 8.8 g/dl; blast cells, 10%; the BEST approach for the management is consistent with acute myeloproliferative disorder
Correct answer
A
Rationale
The correct answer is A) intensive chemotherapy. In this scenario, the presence of blast cells in a 20-day-old infant is concerning for acute myeloproliferative disorder, a condition characterized by abnormal proliferation of myeloid cells in the bone marrow. Intensive chemotherapy is the recommended approach to rapidly reduce the blast cell population and prevent progression of the disease.
Option B) low dose chemotherapy pulses may not be sufficient to effectively target and eliminate the blast cells in this aggressive disorder. Option C) bone marrow transplantation is typically considered in cases of refractory or relapsed disease, not as a first-line treatment in a newly diagnosed case. Option D) close follow up alone is not appropriate given the urgent need for intervention in acute myeloproliferative disorder.
Educationally, understanding the appropriate management of pediatric hematologic disorders is crucial for healthcare providers working in primary care settings. Recognizing the signs and symptoms of acute myeloproliferative disorder and knowing the recommended treatment strategies can help ensure timely and effective care for pediatric patients with such conditions. This case highlights the importance of prompt diagnosis and initiation of appropriate therapy in pediatric hematology-oncology cases.
Option B) low dose chemotherapy pulses may not be sufficient to effectively target and eliminate the blast cells in this aggressive disorder. Option C) bone marrow transplantation is typically considered in cases of refractory or relapsed disease, not as a first-line treatment in a newly diagnosed case. Option D) close follow up alone is not appropriate given the urgent need for intervention in acute myeloproliferative disorder.
Educationally, understanding the appropriate management of pediatric hematologic disorders is crucial for healthcare providers working in primary care settings. Recognizing the signs and symptoms of acute myeloproliferative disorder and knowing the recommended treatment strategies can help ensure timely and effective care for pediatric patients with such conditions. This case highlights the importance of prompt diagnosis and initiation of appropriate therapy in pediatric hematology-oncology cases.